{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:09:04Z","timestamp":1783944544139,"version":"3.55.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400977"],"award-info":[{"award-number":["82400977"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pheochromocytoma is a well-established cause of secondary hypertension and can lead to dysglycemia. However, its initial presentation as atypical diabetes, characterized by severe glycemic instability, is uncommon and poses a significant diagnostic challenge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 49-year-old non-obese Chinese woman presented with a 15-month history of progressive polyuria and polydipsia. Initially diagnosed with type 2 diabetes, she developed significant glycemic variability with recurrent hypoglycemia and profound hyperglycemia, alongside a rapid decline in \u03b2-cell function. During hospitalization, paroxysmal hypertension was observed. Biochemical testing confirmed markedly elevated catecholamines and metabolites. Imaging identified a left adrenal mass, confirmed as pheochromocytoma following laparoscopic adrenalectomy. Postoperatively, all antidiabetic medications were discontinued. At 3-month follow-up, she achieved sustained normoglycemia with restored \u03b2-cell function and normalized blood pressure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case demonstrates that pheochromocytoma can induce a severe, reversible form of diabetes characterized by profound metabolic instability and marked glycemic variability. It highlights the necessity of including pheochromocytoma in the differential diagnosis of patients with atypical, labile diabetes, especially when paroxysmal symptoms are present. Early surgical intervention can reverse these metabolic derangements, often leading to diabetes remission.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1736477","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:15:19Z","timestamp":1767935719000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case report: From metabolic instability to remission: a case of pheochromocytoma presenting as atypical diabetes"],"prefix":"10.3389","volume":"16","author":[{"given":"Chuqing","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingyan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fansu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2011.00699.x","article-title":"alpha2-adrenoceptor regulation of blood glucose homeostasis","volume":"108","author":"Fagerholm","year":"2011","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1907863","article-title":"Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.eprac.2023.07.027","article-title":"Diagnosis and management of pheochromocytomas and paragangliomas: A guide for the clinician","volume":"29","author":"Sharma","year":"2023","journal-title":"Endocr Pract"},{"key":"B4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.10.030","article-title":"Diabetes mellitus in pheochromocytoma and paraganglioma: Prevalence, dynamics of insulin secretion\/sensitivity and predictors of remission","volume":"14","author":"Khatiwada","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.593780","article-title":"Glucose intolerance on phaeochromocytoma and paraganglioma-the current understanding and clinical perspectives","volume":"11","author":"Abe","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2009.01.002","article-title":"The beta3-adrenoceptor as a therapeutic target: current perspectives","volume":"59","author":"Ursino","year":"2009","journal-title":"Pharmacol Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1998.274.4.E700","article-title":"Epinephrine translocates GLUT-4 but inhibits insulin-stimulated glucose transport in rat muscle","volume":"274","author":"Han","year":"1998","journal-title":"Am J Physiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa154","article-title":"Pheochromocytoma with adrenergic biochemical phenotype shows decreased GLP-1 secretion and impaired glucose tolerance","volume":"105","author":"Petrak","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s001250051322","article-title":"Autonomic regulation of islet hormone secretion\u2013implications for health and disease","volume":"43","author":"Ahren","year":"2000","journal-title":"Diabetologia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.14310\/horm.2002.1224","article-title":"Phaeochromocytoma crisis presenting with profound hypoglycaemia and subsequent hypertension","volume":"8","author":"Frankton","year":"2009","journal-title":"Hormones (Athens)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198812013192202","article-title":"Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia","volume":"319","author":"Daughaday","year":"1988","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116152","article-title":"Can \u201cbig\u201d insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia","volume":"90","author":"Zapf","year":"1992","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae879","article-title":"Potential utility of circulating microRNA-483 as a biomarker for IGF-II-associated non-islet cell tumor hypoglycemia","volume":"110","author":"Okazaki-Hada","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ando.2020.01.001","article-title":"Prevalence and progression of carbohydrate disorders in patients with pheochromocytoma\/paraganglioma: retrospective single-center study","volume":"81","author":"Elenkova","year":"2020","journal-title":"Ann Endocrinol (Paris)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5701-6","article-title":"Resection of pheochromocytoma improves diabetes mellitus in the majority of patients","volume":"24","author":"Beninato","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5173\/ceju.2014.04.art9","article-title":"The effect of surgical treatment of phaeochromocytoma on concomitant arterial hypertension and diabetes mellitus in a single-centre retrospective study","volume":"67","author":"Pogorzelski","year":"2014","journal-title":"Cent Eur J Urol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1736477\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:15:19Z","timestamp":1767935719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1736477\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":17,"alternative-id":["10.3389\/fendo.2025.1736477"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1736477","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"article-number":"1736477"}}